What cancer screening tests should a 50-year-old male undergo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cancer Screening Tests for a 50-Year-Old Male

A 50-year-old male should undergo colorectal cancer screening with either annual fecal occult blood testing, colonoscopy every 10 years, or one of the other approved screening methods, and should have a discussion about prostate cancer screening with PSA testing and digital rectal examination. 1

Colorectal Cancer Screening

Colorectal cancer screening is strongly recommended for all average-risk adults beginning at age 50. The following options are available:

  1. Annual high-sensitivity guaiac fecal occult blood testing (FOBT) or fecal immunochemical testing (FIT) 1
  2. Flexible sigmoidoscopy every 5 years 1
  3. Annual FOBT/FIT plus flexible sigmoidoscopy every 5 years (this combination is more accurate than either test alone) 1
  4. Colonoscopy every 10 years 1
  5. Double-contrast barium enema every 5 years 1
  6. Computed tomography colonography every 5 years 1

The American Cancer Society and other organizations consider colonoscopy and annual FIT as first-tier screening tests due to their effectiveness in reducing mortality 2. If colonoscopy is declined, FIT should be offered as an alternative.

Important considerations:

  • In-office single-panel guaiac FOBT using a stool sample collected during digital rectal examination is NOT recommended due to low sensitivity 1
  • High-sensitivity guaiac FOBT or FIT should be used instead of older versions 1
  • Earlier screening is recommended for those with risk factors such as family history of colorectal cancer or polyps 3

Prostate Cancer Screening

For prostate cancer screening at age 50:

  • PSA blood test and digital rectal examination (DRE) should be offered annually to men with at least a 10-year life expectancy 1, 4
  • Men should have an informed discussion about the benefits, risks, and uncertainties of prostate cancer screening before proceeding 1, 4
  • For high-risk men (African Americans and those with a first-degree relative diagnosed with prostate cancer before age 65), screening should begin at age 45 1, 4
  • For very high-risk men (multiple first-degree relatives diagnosed before age 65), screening should begin at age 40 4

PSA testing considerations:

  • A PSA level of 4.0 ng/mL or higher typically warrants further evaluation 4
  • Men with PSA levels < 1.0 ng/mL should be rescreened every 2-4 years 4
  • Men with PSA levels between 1.0-2.5 ng/mL should be rescreened every 2 years 4
  • Men with PSA levels ≥ 2.5 ng/mL should be rescreened annually 4

Cancer-Related Checkup

As part of a periodic health examination, a cancer-related checkup should include:

  • Examination for cancers of the thyroid, testicles, lymph nodes, oral cavity, and skin 1
  • Health counseling regarding tobacco use, sun exposure, diet and nutrition, risk factors, sexual practices, and environmental and occupational exposures 1

Other Important Considerations

  • Lung cancer screening: Currently, there is ongoing evaluation of screening for lung cancer with low-dose computed tomography, but specific recommendations for average-risk individuals are not yet established 1

  • Skin cancer awareness: While routine screening for skin cancer by primary care physicians is not universally recommended for average-risk individuals, awareness of skin changes and monthly self-examination are prudent 1

  • Testicular cancer: Examination of testicles may be included as part of a cancer-related checkup, though routine screening has insufficient evidence for recommendation 1

By following these screening recommendations, a 50-year-old male can significantly reduce his risk of cancer-related mortality through early detection and treatment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prostate Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.